Mabion SA Sustainability Reports
Mabion S.A. is a fully integrated contract development and manufacturing organization (CDMO) specializing in the development and manufacturing of biotherapeutics. The company operates based on monoclonal antibody technology to produce biological medicines and biosimilars.
Sector: Manufacturing
Country: Poland
Exchange: Warsaw Stock Exchange
ISIN: PLMBION00016
12 reports from 2016 to 2025